What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Surgery and Stroke.
His study in Atrial fibrillation, Hazard ratio, Proportional hazards model, Randomized controlled trial and Coronary artery disease falls under the purview of Internal medicine.
The study incorporates disciplines such as Survival rate and Angioplasty in addition to Hazard ratio.
His Surgery study combines topics in areas such as Logistic regression, Heart disease and Risk factor.
His study in Stroke is interdisciplinary in nature, drawing from both Apixaban, Anesthesia, Aspirin and Warfarin.
His work in Heart failure addresses subjects such as Candesartan, which are connected to disciplines such as Placebo.
His most cited work include:
- Apixaban versus Warfarin in Patients with Atrial Fibrillation (5705 citations)
- Predictors of hospital mortality in the global registry of acute coronary events. (1578 citations)
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety (1256 citations)
What are the main themes of his work throughout his whole career to date?
Christopher B. Granger mainly investigates Internal medicine, Cardiology, Myocardial infarction, Atrial fibrillation and Stroke.
His study looks at the relationship between Internal medicine and fields such as Surgery, as well as how they intersect with chemical problems.
Christopher B. Granger combines topics linked to Hazard ratio with his work on Cardiology.
His work in Myocardial infarction addresses issues such as Emergency medicine, which are connected to fields such as Medical emergency.
His research in Atrial fibrillation intersects with topics in Aspirin and Intensive care medicine.
The various areas that Christopher B. Granger examines in his Stroke study include Anesthesia and Proportional hazards model.
He most often published in these fields:
- Internal medicine (69.66%)
- Cardiology (58.81%)
- Myocardial infarction (40.38%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (69.66%)
- Cardiology (58.81%)
- Atrial fibrillation (23.08%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Atrial fibrillation, In patient and Stroke.
All of his Internal medicine and Myocardial infarction, Heart failure, Percutaneous coronary intervention, Randomized controlled trial and Aspirin investigations are sub-components of the entire Internal medicine study.
His Myocardial infarction research is multidisciplinary, incorporating perspectives in Coronary artery disease and Risk factor.
He focuses mostly in the field of Percutaneous coronary intervention, narrowing it down to matters related to Acute coronary syndrome and, in some cases, Conventional PCI.
The concepts of his Cardiology study are interwoven with issues in Biomarker and MEDLINE.
His Stroke study incorporates themes from Proportional hazards model and Hazard ratio.
Between 2017 and 2021, his most popular works were:
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (367 citations)
- Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation (303 citations)
- Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source (195 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Christopher B. Granger focuses on Internal medicine, Cardiology, Atrial fibrillation, Percutaneous coronary intervention and Myocardial infarction.
Internal medicine is a component of his Heart failure, Acute coronary syndrome, Randomized controlled trial, Vitamin K antagonist and Hazard ratio studies.
Christopher B. Granger interconnects Candesartan, Coronary stenting, Cause of death and Kidney disease in the investigation of issues within Cardiology.
His studies deal with areas such as Stroke and Aspirin as well as Atrial fibrillation.
His Percutaneous coronary intervention research focuses on subjects like Antithrombotic, which are linked to Regimen.
As part of one scientific family, Christopher B. Granger deals mainly with the area of Myocardial infarction, narrowing it down to issues related to the Risk factor, and often Cardiac magnetic resonance imaging, Dyslipidemia and Clinical endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
